Article Information
History
- June 11, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Malin Hultcrantz, MD, PhD1,†,
- Joshua Richter, MD2,
- Cara Rosenbaum, MD3,
- Dhwani Patel, MD1,
- Eric Smith, MD PhD1,
- Neha Korde, MD1,
- Sydney Lu, MD PhD1,
- Sham Mailankody, MBBS1,
- Urvi Shah, MD1,
- Alexander Lesokhin, MD1,
- Hani Hassoun, MD1,
- Carlyn Tan, MD1,
- Francesco Maura, MD1,
- Andriy Derkacs4,
- Benjamin Diamond1,
- Adriana Rossi, MD3,
- Roger N. Pearse, MD PhD3,
- Deepu Madduri, MD2,
- Ajai Chari, MD2,
- David Kaminetsky, MD5,
- Marc Braunstein, MD PhD5,
- Christian Gordillo6,
- Faith Davies, MD5,
- Sundar Jagannath, MBBS*,2,
- Ruben Niesvizky, MD*,3,
- Suzanne Lentzsch, MD, PhD*,6,
- Gareth Morgan, MD, PhD*,5 and
- Ola Landgren, MD, PhD*,1,†
- 1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- 2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 3Center for Myeloma, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY, USA
- 4Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- 5Dpt. of Medicine, Multiple Myeloma Research Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
- 6Division of Hematology and Oncology, Columbia University Medical Center, New York, NY, USA
- ↵†Corresponding Authors
Malin Hultcrantz, MD, PhD, Myeloma Service, Department of Medicine; Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA, E-mail: hultcram{at}mskcc.org; Phone 646-608-3714, Ola Landgren, MD, PhD, Myeloma Service, Department of Medicine; Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA, E-mail: landgrec{at}mskcc.org; Phone 646-608-2022
↵* Contributed equally